Combination lipid-lowering therapy as first-line strategy in very high-risk patients

Affiliations

• ¹ Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College London, The Reynolds Building, St Dunstan's Road, London W6 8RP, UK.
• ² Department of Vascular Medicine, Amsterdam University Medical Centers, location AMC, University of Amsterdam, Meibergdreef 9, Amsterdam 1105AZ, the Netherlands.
• ³ Clinic and Policlinic for Cardiology, University Hospital Leipzig, Liebigstraße 20, Leipzig 04103, Germany.
• ⁴ Department of Hypertension, Medical University of Lodz, Zeromskiego 113, Lodz 90-549, Poland.
• ⁵ Department of Cardiology, Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, Geneva 1205, Switzerland.
• ⁶ Department of Cardiology, Hacettepe University Faculty of Medicine, 06100 Sıhhiye, Ankara, Turkey.
• ⁷ Department of Cardiology, Sandwell and West Birmingham Hospitals NHS Trust Birmingham, Institute of Cardiovascular Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
• ⁸ MEDCON International, Adriaan Pauwlaan 29, Heemstede 2101 AJ, the Netherlands.
• ⁹ Vascular Medicine and Metabolism Unit, Research Unit on Lipids and Atherosclerosis, Sant Joan University Hospital, Universitat Rovira i Virgili, IISPV CIBERDEM, Reus 43201, Spain.